Insulet SmartAdjust is an interoperable, automated glycemic control software that connects to an insulin pump and continuous glucose monitor to automatically adjust insulin delivery. The technology was previously approved only for management of Type 1 diabetes, according to an Aug. 26 news release from the FDA.
Individuals with Type 2 diabetes typically manage insulin levels by manually checking blood glucose levels and self-administering insulin one or more times a day.
The Insulet SmartAdjust technology was cleared through the FDA’s 510(k) premarket pathway.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
